REGENERON CELL MEDICINES Trademark

Trademark Overview

On Thursday, July 4, 2024, a trademark application was filed for REGENERON CELL MEDICINES with the United States Patent and Trademark Office. The USPTO has given the REGENERON CELL MEDICINES trademark a serial number of 98625063. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, July 4, 2024. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The REGENERON CELL MEDICINES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; genetically modified cells, genome editing reagents and biological preparations, namely, viral vectors, all for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer

Pharmaceutical research and development services
regeneron cell medicines

General Information

Serial Number98625063
Word MarkREGENERON CELL MEDICINES
Filing DateThursday, July 4, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, July 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; genetically modified cells, genome editing reagents and biological preparations, namely, viral vectors, all for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer
Goods and ServicesPharmaceutical research and development services

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 4, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 4, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Thursday, July 4, 2024NEW APPLICATION ENTERED

Related Keywords

medicines cell regeneron diseases namely system infectious pharmaceutical autoimmune immune cancer genetic treatment